Delivery Order SPE2DR25D3501-SPE2DR26FL9WT
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,898.42 for SKYRIZI 600 mg/10 mL vials on December 11, 2025, with an ultimate completion date of January 5, 2026. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $19,347.63 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of SKYRIZI 600 mg/10 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of SKYRIZI 600 mg/10 mL vials valued at $6,449.21 with a firm fixed price structure. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of December 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and leverage its extensive federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of SKYRIZI 600 mg/10 mL vials with a ceiling value of $6,119.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order is scheduled for completion by November 28, 2025, and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $6,119.69 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of SKYRIZI 600 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,119.69 for SKYRIZI 600 mg/10 mL vials on July 14, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order is not set-aside and represents a competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of SKYRIZI 600 MG/10 ML vials with a ceiling value of $25,796.84. The contract is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through the open...
- The Defense Logistics Agency awarded a delivery order valued at $6,449.21 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 600 mg/10 ml vials on November 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order valued at $35,434.03 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of SKYRIZI 150 mg/mL pen injections. This firm fixed price delivery order, which is not set-aside designated, represents a competitive award under the federal medical procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 21, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,796.82 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML in pen/milliliter format. This firm fixed price delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of December 3, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9WTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,898.42 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 600 mg/10 ml vials on December 4, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 26, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to meet federal procurement standards through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract serves as the vehicle for supplying a broad range of pharmaceutical products and medical supplies to support Department of Defense healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio and established role as a primary pharmaceutical distributor for military and veteran healthcare systems position it to fulfill critical medical supply needs across multiple therapeutic domains for the Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 12/3/25 |